JONES TIMOTHY L. (CEO and President) reported 1 transaction at RESPIRERX PHARMACEUTICALS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/2/2020ACC: 0001493152-20-018823
DirectorOfficer· CEO and President
Since Jan 2020
+8.82M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
8.82M acquired · 28.22 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.41M
Price / share
—
Trade value
—
% of position
New position
9/30/2020
0.00→4.41M
Total
Net shares
+4.41M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2020 | C · Conversion | +4.41M | — | — | New position | 0.00 | 4.41M |
| Total | +4.41M | $0.00 | ||||||
Derivative Transactions3
Series H Preferred Stock
Direct
Converts to
Conversion Units
4.41M shares
Shares
+28.22
Strike price
0.0064
Held after
28.22
Exercisable
—
9/30/2020
Series H Preferred Stock
Direct
Converts to
Conversion Units
4.41M shares
Shares
−28.22
Strike price
0.0064
Held after
0.00
Exercisable
—
9/30/2020
Warrants (to purchase Common Stock)
Direct
Converts to
Common Stock
4.41M shares
Shares
+4.41M
Strike price
0.007
Held after
4.41M
Exercisable
—
9/30/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series H Preferred Stock Direct | Conversion Units4.41M shares | 9/30/2020 | J · J | +28.22 | 0.0064 | — | 28.22 |
| Series H Preferred Stock Direct | Conversion Units4.41M shares | 9/30/2020 | C · Conversion | −28.22 | 0.0064 | — | 0.00 |
| Warrants (to purchase Common Stock) Direct | Common Stock4.41M shares | 9/30/2020 | C · Conversion | +4.41M | 0.007 | — | 4.41M |